Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 89 results:
Συντάκτης Τίτλος Τύπος [ Έτος(Desc)]
Φίλτρα: Συντάκτης is Sarafidis, Pantelis A  [Clear All Filters]
2016
Georgianos, P. I., Mpoutsiouki F., Sabani E., Stamatiadis D. N., Liakopoulos V., Balaskas E. V., et al. (2016).  Hemodialysis patients with intradialytic rise in blood pressure display higher baseline aortic stiffness and negligible drop in augmentation index with dialysis.. Int Urol Nephrol. 48(4), 601-8.
Georgianos, P. I., Sarafidis P. A., Liakopoulos V., Balaskas E. V., & Zebekakis P. E. (2016).  Mineralocorticoid Receptor Antagonism for Cardiovascular Protection in End-Stage Renal Disease: New Data But the Controversy Continues.. J Clin Hypertens (Greenwich). 18(3), 197-9.
Sarafidis, P. A., Stavridis K. C., Loutradis C. N., Saratzis A. N., Pateinakis P., Papagianni A., et al. (2016).  To intervene or not? A man with multidrug-resistant hypertension, endovascular abdominal aneurysm repair, bilateral renal artery stenosis and end-stage renal disease salvaged with renal artery stenting.. Blood Press. 25(2), 123-8.
2017
Sarafidis, P. A., Lazaridis A. A., Ruiz-Hurtado G., & Ruilope L. M. (2017).  Blood pressure reduction in diabetes: lessons from ACCORD, SPRINT and EMPA-REG OUTCOME.. Nat Rev Endocrinol. 13(6), 365-374.
Karpetas, A., Loutradis C., Bikos A., Tzanis G., Koutroumpas G., Lazaridis A. A., et al. (2017).  Blood pressure variability is increasing from the first to the second day of the interdialytic interval in hemodialysis patients.. J Hypertens. 35(12), 2517-2526.
Loutradis, C. N., Tsioufis C., & Sarafidis P. A. (2017).  The Clinical Problems of Hypertension Treatment in Hemodialysis Patients.. Curr Vasc Pharmacol. 16(1), 54-60.
Jhaveri, K. D., Saratzis A. N., Wanchoo R., & Sarafidis P. A. (2017).  Endovascular aneurysm repair (EVAR)- and transcatheter aortic valve replacement (TAVR)-associated acute kidney injury.. Kidney Int. 91(6), 1312-1323.
Sarafidis, P. A., Kamperidis V., Loutradis C., Tsilonis K., Mpoutsiouki F., Saratzis A., et al. (2017).  Haemodialysis acutely deteriorates left and right diastolic function and myocardial performance: an effect related to high ultrafiltration volumes?. Nephrol Dial Transplant. 32(8), 1402-1409.
Sarafidis, P. A., Persu A., Agarwal, iv R., Burnier M., de Leeuw P., Ferro C. J., et al. (2017).  Hypertension in dialysis patients: a consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) and the Hypertension and the Kidne. Nephrol Dial Transplant. 32(4), 620-640.
Sarafidis, P. A., Persu A., Agarwal, iv R., Burnier M., de Leeuw P., Ferro C., et al. (2017).  Hypertension in dialysis patients: a consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) and the Hypertension and the Kid. J Hypertens. 35(4), 657-676.
Halimi, J-M., Persu A., Sarafidis P. A., Burnier M., Abramowicz D., Sautenet B., et al. (2017).  Optimizing hypertension management in renal transplantation: a call to action.. Nephrol Dial Transplant. 32(12), 1959-1962.
2018
Georgianou, E., Georgianos P. I., Petidis K., Athyros V. G., Sarafidis P. A., & Karagiannis A. (2018).  Antihypertensive therapy in acute ischemic stroke: where do we stand?. J Hum Hypertens. 32(12), 799-807.
Mayer, C. C., Matschkal J., Sarafidis P. A., Hagmair S., Lorenz G., Angermann S., et al. (2018).  Association of Ambulatory Blood Pressure with All-Cause and Cardiovascular Mortality in Hemodialysis Patients: Effects of Heart Failure and Atrial Fibrillation.. J Am Soc Nephrol. 29(9), 2409-2417.
Sarafidis, P. A., Ruilope L. M., Loutradis C., Gorostidi M., de la Sierra A., de la Cruz J. J., et al. (2018).  Blood pressure variability increases with advancing chronic kidney disease stage: a cross-sectional analysis of 16 546 hypertensive patients.. J Hypertens. 36(5), 1076-1085.
Loutradis, C., Sarafidis P. A., Papadopoulos C. E., Papagianni A., & Zoccali C. (2018).  The Ebb and Flow of Echocardiographic Cardiac Function Parameters in Relationship to Hemodialysis Treatment in Patients with ESRD.. J Am Soc Nephrol. 29(5), 1372-1381.
Raptis, V., Bakogiannis C., Loutradis C., Boutou A. K., Lampropoulou I., Intzevidou E., et al. (2018).  Levels of Endocan, Angiopoietin-2, and Hypoxia-Inducible Factor-1a in Patients with Autosomal Dominant Polycystic Kidney Disease and Different Levels of Renal Function.. Am J Nephrol. 47(4), 231-238.
Sarafidis, P. A., Memmos E., Alexandrou M-E., & Papagianni A. (2018).  Mineralocorticoid Receptor Antagonists for Nephroprotection: Current Evidence and Future Perspectives.. Curr Pharm Des. 24(46), 5528-5536.
Sarafidis, P. A., Mallamaci F., Loutradis C., Ekart R., Torino C., Karpetas A., et al. (2018).  Prevalence and control of hypertension by 48-h ambulatory blood pressure monitoring in haemodialysis patients: a study by the European Cardiovascular and Renal Medicine (EURECA-m) working group of the ERA-EDTA.. Nephrol Dial Transplant. 33(10), 1872.
Raptis, V., Loutradis C., & Sarafidis P. A. (2018).  Renal injury progression in autosomal dominant polycystic kidney disease: a look beyond the cysts.. Nephrol Dial Transplant. 33(11), 1887-1895.
Raptis, V., Bakogiannis C., Loutradis C., Boutou A. K., Sioulis A., Balaskas E., et al. (2018).  Serum Fas Ligand, Serum Myostatin and Urine TGF-β1 Are Elevated in Autosomal Dominant Polycystic Kidney Disease Patients with Impaired and Preserved Renal Function.. Kidney Blood Press Res. 43(3), 744-754.
2019
Sarafidis, P. A., Loutradis C., Karpetas A., Tzanis G., Bikos A., Raptis V., et al. (2019).  The association of interdialytic blood pressure variability with cardiovascular events and all-cause mortality in haemodialysis patients.. Nephrol Dial Transplant. 34(3), 515-523.
Matschkal, J., Mayer C. C., Sarafidis P. A., Lorenz G., Braunisch M. C., Guenthner R., et al. (2019).  Comparison of 24-hour and Office Pulse Wave Velocity for Prediction of Mortality in Hemodialysis Patients.. Am J Nephrol. 49(4), 317-327.
Loutradis, C., Sarafidis P. A., Ekart R., Papadopoulos C., Sachpekidis V., Alexandrou M. Eleni, et al. (2019).  The effect of dry-weight reduction guided by lung ultrasound on ambulatory blood pressure in hemodialysis patients: a randomized controlled trial.. Kidney Int. 95(6), 1505-1513.
Bikos, A., Loutradis C., Angeloudi E., Karpetas A., Raptis V., Kalaitzidis R., et al. (2019).  The effects of nebivolol and irbesartan on postdialysis and ambulatory blood pressure in patients with intradialytic hypertension: a randomized cross-over study.. J Hypertens. 37(2), 432-442.
Stavrinou, E., Sarafidis P. A., Koumaras C., Loutradis C., Giamalis P., Tziomalos K., et al. (2019).  Increased Sclerostin, but Not Dickkopf-1 Protein, Is Associated with Elevated Pulse Wave Velocity in Hemodialysis Subjects.. Kidney Blood Press Res. 44(4), 679-689.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές